Calprotectin: Clinical applications in pediatrics

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin’s basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin’s use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.

Original languageEnglish (US)
Pages (from-to)308-321
Number of pages14
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume21
Issue number4
DOIs
StatePublished - Jul 1 2016

Fingerprint

Leukocyte L1 Antigen Complex
Pediatrics
Body Fluids
Inflammation
Biomarkers
Biomedical Research
Newborn Infant

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Cite this

Calprotectin : Clinical applications in pediatrics. / Herrera, Oscar Rafael; Christensen, Michael L.; Helms, Richard A.

In: Journal of Pediatric Pharmacology and Therapeutics, Vol. 21, No. 4, 01.07.2016, p. 308-321.

Research output: Contribution to journalReview article

@article{274a9ef2f6514e8eab83dc9afa549351,
title = "Calprotectin: Clinical applications in pediatrics",
abstract = "As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin’s basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin’s use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.",
author = "Herrera, {Oscar Rafael} and Christensen, {Michael L.} and Helms, {Richard A.}",
year = "2016",
month = "7",
day = "1",
doi = "10.5863/1551-6776-21.4.308",
language = "English (US)",
volume = "21",
pages = "308--321",
journal = "Journal of Pediatric Pharmacology and Therapeutics",
issn = "1551-6776",
publisher = "Pediatric Pharmacology Advocacy Group, Inc.",
number = "4",

}

TY - JOUR

T1 - Calprotectin

T2 - Clinical applications in pediatrics

AU - Herrera, Oscar Rafael

AU - Christensen, Michael L.

AU - Helms, Richard A.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin’s basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin’s use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.

AB - As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin’s basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin’s use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.

UR - http://www.scopus.com/inward/record.url?scp=85032018003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032018003&partnerID=8YFLogxK

U2 - 10.5863/1551-6776-21.4.308

DO - 10.5863/1551-6776-21.4.308

M3 - Review article

AN - SCOPUS:85032018003

VL - 21

SP - 308

EP - 321

JO - Journal of Pediatric Pharmacology and Therapeutics

JF - Journal of Pediatric Pharmacology and Therapeutics

SN - 1551-6776

IS - 4

ER -